In HER2-positive early breast cancer, Kadcyla shows sustained improvement in both invasive disease-free survival and overall survival versus Herceptin.

Antibody-drug conjugates have had a tremendous impact on breast cancer care and treatment, according to Dr. Charles E. Geyer.

It is recommended that women with early HER2+ breast cancer receive neoadjuvant subtype-specific systemic therapy, followed by surgery. 3 Paclitaxel plus trastuzumab, docetaxel/carboplatin ...

In a collaborative mission, One Piece artist Ado's voice recordings have been sent to space along with Elon Musk's SpaceX Falcon 9 rocket.

Reclusive Japanese singing sensation Ado is reaching astronomical new heights — literally — as her music travels beyond Earth’s atmosphere in an initiative backed by Elon Musk‘s SpaceX.

Ado, Atarashii Gakko! and Yoasobi are unique and eccentric Japanese musicians who are contributing to bringing the excitement of J-pop worldwide. Fans are in for a treat because these musical acts ...

The study by Ma et al. provides fundamental findings and compelling evidence that Pyrotinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (PERSIST): A ...

This study provides valuable insights into the efficacy and safety of pyrotinib as an extended adjuvant therapy following trastuzumab-based treatment in patients with high-risk HER2-positive breast ...

1Department of Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, Texas. Search for other works by this author on: 1Department of Investigational Cancer ...

Copyright: © 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies. The most successful ...